Amae Health Announces $25 Million Series B to Advance Toward a Cure for Severe Mental Illness

阿玛健康宣布获得2500万美元B轮融资，以推进对严重精神疾病的治疗

The Series B round, led by Altos Ventures with participation from existing investors, will accelerate Amae’s AI-powered precision-care platform and partnerships with leading academic medical centers—marking a decisive step toward curative psychiatry

B轮融资由Altos Ventures领投，现有投资者参与，将加速Amae的AI驱动精准护理平台及与领先的学术医疗中心的合作，标志着向治愈性精神病学迈出了关键一步。

SAN FRANCISCO, November 6, 2025-- More than 15 million Americans live with severe mental illness (SMI) and remain stuck in a cycle of crisis care. Amae Health, a Public Benefit Corporation (PBC) and leader in outpatient treatment for SMI, today announced a $25 million pre-empted Series B financing, bringing total funding to more than $50 million, to transform how these conditions are understood, treated, and ultimately cured.

旧金山，2025年11月6日——超过1500万美国人患有严重精神疾病（SMI），并陷入危机护理的循环中。Amae Health是一家公共利益公司（PBC），也是SMI门诊治疗的领导者，今天宣布已完成2500万美元的预先进行的B轮融资，总融资额超过5000万美元，旨在改变这些疾病的认知、治疗方式，并最终实现治愈。

The round was led by Altos Ventures with participation from all existing investors, including Quiet Capital, Bling Capital, Cedars-Sinai Ventures, Healthier Capital, and 8VC..

本轮融资由Altos Ventures领投，所有现有投资者均参与其中，包括Quiet Capital、Bling Capital、Cedars-Sinai Ventures、Healthier Capital和8VC。

The new funding will accelerate the opening of Amae clinics nationwide, advance its proprietary AI-driven care platform, and support research into schizophrenia, bipolar disorder, and treatment-resistant depression. It will also strengthen partnerships with leading academic medical centers to expand access to Amae’s integrated model of care..

新资金将加速Amae诊所在全国范围内的开设，推动其专有的人工智能驱动护理平台的发展，并支持对精神分裂症、双相情感障碍和难治性抑郁症的研究。同时，它还将加强与领先的学术医疗中心的合作，以扩大对Amae综合护理模式的获取途径。

“Severe mental illness devastates families and communities, yet traditional treatment models haven’t moved the needle,” said Stas Sokolin, Co-Founder and CEO of Amae Health. “We’re taking a different path; combining compassionate, in-person care with responsibly deployed AI that helps clinicians determine the best course for each individual.

“严重的精神疾病摧毁家庭和社区，但传统的治疗模式并没有起到作用，”Amae Health的联合创始人兼首席执行官斯塔斯·索科林表示。“我们正在走一条不同的道路；将富有同情心的面对面护理与负责任地部署的人工智能相结合，帮助临床医生为每个个体确定最佳方案。”

Our north star is a true cure, defined as it is in oncology: five or more years of remission.”.

我们的北极星是一个真正的治愈，正如肿瘤学中所定义的：五年或更长时间的缓解。

Expanding In-Person SMI Care Across the Country

在全国范围内扩展面对面的严重精神疾病护理

Since opening its first clinic in Los Angeles in 2022, Amae has partnered with leading health systems including NewYork-Presbyterian, Cedars-Sinai and Stanford Health Care to bring high-quality, team-based outpatient care to communities in need. Clinics staffed by psychiatrists, therapists, primary care providers, dietitians, and social services specialists deliver coordinated treatment tailored to each patient..

自2022年在洛杉矶开设第一家诊所以来，Amae与包括纽约长老会医院、西达赛奈医疗中心和斯坦福医疗在内的领先卫生系统合作，为有需要的社区提供高质量的团队式门诊服务。诊所由精神科医生、治疗师、初级保健医生、营养师和社会服务专家组成，提供针对每位患者的协调治疗。

Unlike virtual-only or chatbot-driven models, Amae combines face-to-face care with advanced technology that truly supports and empowers our clinicians. This approach has achieved striking results:

与仅虚拟或聊天机器人驱动的模式不同，Amae 将面对面护理与真正支持和赋能临床医生的先进技术相结合。这种方法取得了显著的成果：

• Reduced 30-day hospital readmissions to <4%, compared to a 23% national average

• 将30天内医院再入院率降低至<4%，而全国平均水平为23%

• Attained measurement-based care score improvements of 76% in mania, 61% in psychosis, and 49% in suicidality

• 在躁狂症方面达到了76%的基于测量的护理评分改善，在精神病方面为61%，在自杀倾向方面为49%。

• Delivered 100% 7-day and 30-day post-hospitalization follow-up through Amae’s same-day intake model

• 通过Amae的当日接收模式，完成了100%的出院后7天和30天随访

• Achieved a Net Promoter Score (NPS) of 90, reflecting exceptional patient experience

• 获得了90的净推荐值 (NPS)，反映了卓越的患者体验

“Amae is advancing a model of care that prioritizes clinical excellence and compassionate, patient-centered services,” said Dr. Itai Danovitch, Chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center. “By combining an outstanding team of clinicians with a thoughtful approach to long-term care, Amae is delivering outcomes that are both significant and sustainable.”.

“Amae正在推进一种注重临床卓越性和富有同情心、以患者为中心的服务的护理模式，”西达赛奈医疗中心精神病学与行为神经科学系主任Itai Danovitch博士说道。“通过将一支优秀的临床医生团队与对长期护理的周到方法相结合，Amae取得了既重要又可持续的成果。”

Responsible AI Features that Enhance Patient Care

负责任的人工智能功能提升患者护理

Amae’s precision medicine platform is built on Palantir Foundry and integrates data from wearables, measurement-based assessments, and patient records. This system enables providers to identify patterns, track treatment response, and coordinate across the full care team.

阿玛伊的精准医疗平台建立在帕兰蒂尔铸造厂系统之上，整合了来自可穿戴设备、基于测量的评估和患者记录的数据。该系统使医疗服务提供者能够识别模式、跟踪治疗反应，并在整个护理团队中进行协调。

Three new features are reshaping how clinicians care for patients:

三种新特性正在重塑临床医生照顾患者的方式：

• Patient-at-a-Glance: A unified dashboard that synthesizes inputs from clinical assessments, wearables, and health records to give providers a clear, longitudinal view of each patient’s progress.

• 患者一览：一个统一的仪表板，整合了临床评估、可穿戴设备和健康记录的输入，为医疗人员提供每位患者进展的清晰纵向视图。

• Point of Care Assistant: An AI-powered clinical assistant that monitors patient status, flags meaningful changes, and offers treatment recommendations. Providers remain fully in control, approving or adjusting each suggestion with their judgment.

• 护理点助手：一款人工智能驱动的临床助手，能够监测患者状态、标记重要变化并提供治疗建议。医疗服务提供者全程掌控，凭借自己的判断批准或调整每项建议。

• Symptomology Phenotyping: Symptom clustering based on longitudinal patient data allows for the creation of digital phenotypes. Providers can use these phenotypes to deliver highly effective, precise care based on a patient’s unique set of symptoms.

症状学表型分析：基于纵向患者数据的症状聚类能够创建数字表型。医疗提供者可以利用这些表型，根据患者的独特症状提供高效且精准的护理。

These features have allowed Amae to set a new standard for SMI care, one that pairs the scalability of AI with the deep precision, and humanity of in-person treatment. Deployed alongside leading health systems across the country, this model has the potential to fundamentally reshape how SMI is treated, and ultimately, how it’s cured..

这些特征使Amae能够为严重精神疾病（SMI）护理设立一个新的标准，这个标准将人工智能的可扩展性与当面治疗的深度精确性和人性化相结合。与全国领先的卫生系统一起部署，这个模式有潜力从根本上重塑严重精神疾病的治疗方法，并最终改变治愈它的途径。

The Amae Institute: Accelerating the Path to Cures

阿玛伊研究所：加速治愈之路

To further its mission, Amae has established the Amae Institute, a center for excellence dedicated to advancing care for SMI. The Amae Institute partners with leading research hospitals and academic experts to develop next-generation treatments and accelerate the scientific progress needed to achieve long-term remission and, ultimately, a cure..

为了进一步实现其使命，阿玛伊建立了阿玛伊研究所，这是一个致力于推进严重精神疾病护理的卓越中心。阿玛伊研究所与领先的研究医院和学术专家合作，开发下一代治疗方法，并加速实现长期缓解，最终达到治愈所需的科学进展。

Learn more at https://www.amaehealth.com/amae-institute

了解更多，请访问 https://www.amaehealth.com/amae-institute

About Amae Health

关于Amae Health

Amae Health is dedicated to helping the 15.4 million Americans living with severe mental illness (SMI) lead stable, fulfilling lives – and ending the cycle of repeat hospitalizations. Partnering with top health systems nationwide, Amae delivers a groundbreaking outpatient model that combines compassionate, in-person psychiatric care with wraparound support and AI-powered clinical tools.

Amae Health 致力于帮助美国1540万患有严重精神疾病（SMI）的人过上稳定且充实的生活，并终结反复住院的循环。通过与全国顶级卫生系统合作，Amae 提供了一种突破性的门诊模式，将富有同情心的面对面精神科护理与全方位支持及人工智能临床工具相结合。

By treating physical, mental, and social needs together, Amae enables its members to not just survive, but thrive..

通过共同满足身体、心理和社会需求，Amae使其成员不仅能够生存，而且能够茁壮成长。

Learn more at www.amaehealth.com

更多信息请访问 www.amaehealth.com

Contact:

联系人：

Leigh Disher

Leigh Disher

GMK Communications for Amae

GMK通信为Amae

leigh@gmkcommunications.com

leigh@gmkcommunications.com